• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定帕金森病相关的染色质调控因子。

Identification of Parkinson's disease-associated chromatin regulators.

机构信息

Department of Neurosurgery, Binzhou Medical University Hospital, Binzhou, Shandong, China.

Department of Neurosurgery, Binzhou Central Hospital, Binzhou, Shandong, China.

出版信息

Sci Rep. 2023 Feb 22;13(1):3084. doi: 10.1038/s41598-023-30236-4.

DOI:10.1038/s41598-023-30236-4
PMID:36813848
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9947017/
Abstract

Parkinson's disease (PD) is a common neurological disorder that causes quiescent tremors, motor delays, depression, and sleep disturbances. Existing treatments can only improve symptoms, not stop progression or cure the disease, but effective treatments can significantly improve patients' quality of life. There is growing evidence that chromatin regulatory proteins (CRs) are involved in a variety of biological processes, including inflammation, apoptosis, autophagy, and proliferation. But the relationship of chromatin regulators in Parkinson's disease has not been studied. Therefore, we aim to investigate the role of CRs in the pathogenesis of Parkinson's disease. We collected 870 chromatin regulatory factors from previous studies and downloaded data on patients with PD from the GEO database. 64 differentially expressed genes were screened, the interaction network was constructed and the key genes with the top 20 scores were calculated. Then we discussed its correlation with the immune function of PD. Finally, we screened potential drugs and miRNAs. Five genes related to the immune function of PD, BANF1, PCGF5, WDR5, RYBP and BRD2, were obtained by using the absolute value of correlation greater than 0.4. And the disease prediction model showed good predictive efficiency. We also screened 10 related drugs and 12 related miRNAs, which provided a reference for the treatment of PD. BANF1, PCGF5, WDR5, RYBP and BRD2 are related to the immune process of Parkinson's disease and can predict the occurrence of Parkinson's disease, which is expected to become a new target for the diagnosis and treatment of Parkinson's disease.

摘要

帕金森病(PD)是一种常见的神经退行性疾病,会导致静止性震颤、运动迟缓、抑郁和睡眠障碍。现有的治疗方法只能改善症状,无法阻止疾病进展或治愈疾病,但有效的治疗方法可以显著提高患者的生活质量。越来越多的证据表明染色质调节蛋白(CRs)参与了多种生物学过程,包括炎症、细胞凋亡、自噬和增殖。但是,染色质调节因子在帕金森病中的关系尚未得到研究。因此,我们旨在研究 CRs 在帕金森病发病机制中的作用。我们从之前的研究中收集了 870 个染色质调节因子,并从 GEO 数据库中下载了 PD 患者的数据。筛选出 64 个差异表达基因,构建了相互作用网络,并计算了得分最高的 20 个关键基因。然后我们讨论了它与帕金森病免疫功能的关系。最后,我们筛选了潜在的药物和 miRNA。通过使用相关性绝对值大于 0.4,获得了与 PD 免疫功能相关的 5 个基因,BANF1、PCGF5、WDR5、RYBP 和 BRD2。并且疾病预测模型显示出良好的预测效率。我们还筛选出 10 种相关药物和 12 种相关 miRNA,为 PD 的治疗提供了参考。BANF1、PCGF5、WDR5、RYBP 和 BRD2 与帕金森病的免疫过程有关,可以预测帕金森病的发生,有望成为帕金森病诊断和治疗的新靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/fd00fa5afca0/41598_2023_30236_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/ca54f5525db5/41598_2023_30236_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/9367b534cf13/41598_2023_30236_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/91a26118a9a2/41598_2023_30236_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/8aa0c0accce8/41598_2023_30236_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/305223e21fb0/41598_2023_30236_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/e52fe6bf9b11/41598_2023_30236_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/ea3d8423336c/41598_2023_30236_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/fd00fa5afca0/41598_2023_30236_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/ca54f5525db5/41598_2023_30236_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/9367b534cf13/41598_2023_30236_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/91a26118a9a2/41598_2023_30236_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/8aa0c0accce8/41598_2023_30236_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/305223e21fb0/41598_2023_30236_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/e52fe6bf9b11/41598_2023_30236_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/ea3d8423336c/41598_2023_30236_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5a08/9947017/fd00fa5afca0/41598_2023_30236_Fig8_HTML.jpg

相似文献

1
Identification of Parkinson's disease-associated chromatin regulators.鉴定帕金森病相关的染色质调控因子。
Sci Rep. 2023 Feb 22;13(1):3084. doi: 10.1038/s41598-023-30236-4.
2
Identification of Chromatin Regulatory Factors Related to Immunity and Treatment of Alzheimer's Disease.鉴定与免疫和阿尔茨海默病治疗相关的染色质调节因子。
J Mol Neurosci. 2023 Mar;73(2-3):85-94. doi: 10.1007/s12031-023-02107-0. Epub 2023 Feb 24.
3
Identification of regulatory relationships in Parkinson's disease.帕金森病调控关系的鉴定。
J Mol Neurosci. 2013 Sep;51(1):9-12. doi: 10.1007/s12031-012-9937-8. Epub 2013 Feb 21.
4
Integrative analysis of potential biomarkers and immune cell infiltration in Parkinson's disease.帕金森病潜在生物标志物与免疫细胞浸润的整合分析。
Brain Res Bull. 2021 Dec;177:53-63. doi: 10.1016/j.brainresbull.2021.09.010. Epub 2021 Sep 16.
5
miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.血液中的微小RNA和靶基因作为帕金森病早期诊断的生物标志物。
BMC Syst Biol. 2019 Jan 21;13(1):10. doi: 10.1186/s12918-019-0680-4.
6
Identifying the hub gene and immune infiltration of Parkinson's disease using bioinformatical methods.使用生物信息学方法鉴定帕金森病的枢纽基因和免疫浸润。
Brain Res. 2022 Jun 15;1785:147879. doi: 10.1016/j.brainres.2022.147879. Epub 2022 Mar 10.
7
Comprehensive Analysis and Experimental Validation of the Parkinson's Disease Lysosomal Gene ACP2 and Pan-cancer.帕金森病溶酶体基因ACP2与泛癌的综合分析及实验验证
Biochem Genet. 2024 Dec;62(6):4408-4431. doi: 10.1007/s10528-023-10652-x. Epub 2024 Feb 3.
8
A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.对公共微阵列数据的荟萃分析确定了帕金森病中的生物调节网络。
BMC Med Genomics. 2018 Apr 13;11(1):40. doi: 10.1186/s12920-018-0357-7.
9
Diagnosis and Drug Prediction of Parkinson's Disease Based on Immune-Related Genes.基于免疫相关基因的帕金森病诊断与药物预测
J Mol Neurosci. 2022 Sep;72(9):1809-1819. doi: 10.1007/s12031-022-02043-5. Epub 2022 Jun 22.
10
Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.基因表达和调控网络互作数据的综合分析揭示蛋白激酶 C 家族丝氨酸/苏氨酸受体是帕金森病的一个重要可药物靶点。
J Mol Neurosci. 2021 Mar;71(3):466-480. doi: 10.1007/s12031-020-01669-7. Epub 2020 Jul 29.

引用本文的文献

1
Locus in Parkinson's Disease Patients of Ashkenazi Origin: A Stratified Analysis.帕金森病患者阿什肯纳兹血统中的基因座:分层分析。
Genes (Basel). 2023 Dec 28;15(1):46. doi: 10.3390/genes15010046.

本文引用的文献

1
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
2
Targeting epigenetics as a promising therapeutic strategy for treatment of neurodegenerative diseases.将表观遗传学作为治疗神经退行性疾病的一种有前景的治疗策略。
Biochem Pharmacol. 2022 Dec;206:115295. doi: 10.1016/j.bcp.2022.115295. Epub 2022 Oct 12.
3
Role of BET Proteins in Inflammation and CNS Diseases.BET蛋白在炎症和中枢神经系统疾病中的作用。
Front Mol Biosci. 2021 Sep 16;8:748449. doi: 10.3389/fmolb.2021.748449. eCollection 2021.
4
cGAS-STING-mediated IFN-I Response in Host Defense and Neuroinflammatory Diseases.cGAS-STING 介导的固有免疫与神经炎性疾病中的 IFN-I 反应
Curr Neuropharmacol. 2022;20(2):362-371. doi: 10.2174/1570159X19666210924110144.
5
Histamine in the Crosstalk Between Innate Immune Cells and Neurons: Relevance for Brain Homeostasis and Disease.组胺在固有免疫细胞与神经元的串扰中:对脑稳态和疾病的意义
Curr Top Behav Neurosci. 2022;59:261-288. doi: 10.1007/7854_2021_235.
6
Neuromodulation Approaches in Parkinson's Disease Using Deep Brain Stimulation and Transcranial Magnetic Stimulation.帕金森病的神经调节方法:深部脑刺激与经颅磁刺激。
J Geriatr Psychiatry Neurol. 2021 Jul;34(4):301-309. doi: 10.1177/08919887211018269.
7
Parkinson's disease.帕金森病。
Lancet. 2021 Jun 12;397(10291):2284-2303. doi: 10.1016/S0140-6736(21)00218-X. Epub 2021 Apr 10.
8
WD repeat domain 5 promotes chemoresistance and Programmed Death-Ligand 1 expression in prostate cancer.WD 重复结构域 5 促进前列腺癌的化疗耐药和程序性死亡配体 1 的表达。
Theranostics. 2021 Mar 4;11(10):4809-4824. doi: 10.7150/thno.55814. eCollection 2021.
9
Barrier-to-autointegration-factor (Banf1) modulates DNA double-strand break repair pathway choice via regulation of DNA-dependent kinase (DNA-PK) activity.屏障整合因子 1(Banf1)通过调节 DNA 依赖性激酶(DNA-PK)活性来调节 DNA 双链断裂修复途径的选择。
Nucleic Acids Res. 2021 Apr 6;49(6):3294-3307. doi: 10.1093/nar/gkab110.
10
Parkinson's Disease-Associated LRRK2 Interferes with Astrocyte-Mediated Alpha-Synuclein Clearance.帕金森病相关 LRRK2 干扰星形胶质细胞介导的α-突触核蛋白清除。
Mol Neurobiol. 2021 Jul;58(7):3119-3140. doi: 10.1007/s12035-021-02327-8. Epub 2021 Feb 24.